AI has the potential to be able to improve disparities by early detection, and the use of those tools will then translate into improved outcomes and improved screening rates, which will then lead to reduced cancer rates for those low- to middle-income countries. The challenge, I think, with this is that it requires infrastructure to be able to make those things happen...
AI has the potential to be able to improve disparities by early detection, and the use of those tools will then translate into improved outcomes and improved screening rates, which will then lead to reduced cancer rates for those low- to middle-income countries. The challenge, I think, with this is that it requires infrastructure to be able to make those things happen. And it will also require a lot of upfront capital costs to be able to implement those things successfully in a long-term measure as well, too. So I think those are probably the main barriers at this point in time. But I think ASCO and many other organizations are committed to being able to help invest those resources along with many other companies to help level the playing field for those experiencing cancer throughout the world.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
